Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
10,434
Value
$850.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARWR by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,434$850.5K<0.1%−21,064−66.9%ReducedHolders
Q1 202631,498$1.97M<0.1%−357−1.1%ReducedHolders
Q4 202531,855$2.11M<0.1%+3,897+13.9%AddedHolders
Q3 202527,958$964.3K<0.1%−4,218−13.1%ReducedHolders
Q2 202532,176$508.4K<0.1%−1,751−5.2%ReducedHolders
Q1 202533,927$432.2K<0.1%−11,403−25.2%ReducedHolders
Q4 202445,330$852.2K<0.1%+10,005+28.3%AddedHolders
Q3 202435,325$684.2K<0.1%+6,244+21.5%AddedHolders
Q2 202429,081$755.8K<0.1%−6,511−18.3%ReducedHolders
Q1 202435,592$1.02M<0.1%+6,341+21.7%AddedHolders
Q4 202329,251$895.1K<0.1%+3,308+12.8%AddedHolders
Q3 202325,943$697.1K<0.1%−553−2.1%ReducedHolders
Q2 202326,496$944.8K<0.1%+428+1.6%AddedHolders
Q1 202326,068$662.1K<0.1%−4,077−13.5%ReducedHolders
Q4 202230,145$1.22M<0.1%+2,424+8.7%AddedHolders
Q3 202227,721$917.0K<0.1%+384+1.4%AddedHolders
Q2 202227,337$962.0K<0.1%−13,321−32.8%ReducedHolders
Q1 202240,658$1.87M<0.1%−8,236−16.8%ReducedHolders
Q4 202148,894$3.24M<0.1%+3,971+8.8%AddedHolders
Q3 202144,923$2.81M<0.1%−7,938−15.0%ReducedHolders
Q2 202152,861$4.38M<0.1%+3,130+6.3%AddedHolders
Q1 202149,731$3.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.